Radical concurrent chemoradiotherapy (CRT) for non-small cell lung cancer (NSCLC)

被引：0
|
作者：
Stilwell, C. H. [1 ]
Shrimali, R. K. [1 ]
Sharma, R. N. [1 ]
Nicolson, M. C. [1 ]
Steven, E. [1 ]
Bissett, J. D. [1 ]
机构：
[1] Aberdeen Royal Infirm, Aberdeen, Scotland
来源：
LUNG CANCER | 2013年 / 79卷
关键词：
D O I：
10.1016/S0169-5002(13)70182-X
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
182
引用
收藏
页码：S62 / S63
页数：2
相关论文
共 50 条
  • [1] Radical radiotherapy (RT) and chemoradiotherapy (CRT) in non-small cell lung cancer (NSCLC): Outcomes from a regional cancer network
    Abdul-Latif, M. A.
    English, S.
    Fernandes, J.
    Singer, J.
    Chowdhury, S.
    Anand, G.
    ANNALS OF ONCOLOGY, 2020, 31 : S810 - S810
  • [2] Concurrent chemoradiotherapy in non-small cell lung cancer
    O'Rourke, Noelle
    Roque i Figuls, Marta
    Farre Bernado, Nuria
    Macbeth, Fergus
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2010, (06):
  • [3] Phase I study of vorinostat with concurrent chemoradiotherapy (CRT) for locally advanced non-squamous non-small cell lung cancer (NSCLC).
    Mehra, Ranee
    Turaka, Aruna
    Meyer, Joshua E.
    Egleston, Brian L.
    Tanvetyanon, Tawee
    Pinder, Mary Colleen
    Dilling, Thomas J.
    Williams, Charles C.
    Gray, Jhanelle Elaine
    Shirai, Keisuke
    Alpaugh, R. Katherine
    Riordan, Debbie
    Somaiah, Neeta
    Shah, Prashant C.
    Scott, Walter Joseph
    Simon, George R.
    Borghaei, Hossein
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [4] Induction and concurrent chemoradiotherapy for non-small cell lung cancer (NSCLC) using cisplatin and vinorelbine
    Ho, G. Fuang
    Popat, S.
    Nutting, C.
    LUNG CANCER, 2008, 60 : S18 - S18
  • [5] A single institution experience on concurrent chemoradiotherapy (CCT) in non-small cell lung cancer (NSCLC)
    Choudhury, Mahbuba
    MuthuKumar, Dakshinamoorthy
    LUNG CANCER, 2021, 156 : S55 - S55
  • [6] Concurrent chemoradiotherapy with paclitaxel and carboplatin for locoregionally advanced non-small cell lung cancer (NSCLC)
    Kaplanova, J.
    Tomiskova, M.
    Babickova, L.
    Kadlec, B.
    Slampa, P.
    Skrickova, J.
    LUNG CANCER, 2006, 52 : S34 - S34
  • [7] Results of concurrent chemoradiotherapy (CRT) with low dose weekly gemcitabine (G) in stage III non-small cell lung cancer (NSCLC).
    Abacioglu, U
    Yumuk, PF
    Caglar, H
    Sengoz, M
    Turhal, NS
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 695S - 695S
  • [8] Phase 2 Study of Nimotuzumab in Combination With Concurrent Chemoradiotherapy (CRT) in Patients With Locally Advanced Non-small Cell Lung Cancer (NSCLC)
    Tanaka, K.
    Okamoto, I.
    Yamamoto, N.
    Hattori, Y.
    Masuda, N.
    Nishio, M.
    Takeda, K.
    Seto, T.
    Nishimura, Y.
    Nakagawa, K.
    EUROPEAN JOURNAL OF CANCER, 2011, 47 : S605 - S605
  • [9] Induction chemotherapy followed by concurrent chemoradiotherapy (CRT) and surgery in locally advanced non-small cell lung carcinoma (NSCLC)
    Costa, MA
    Zukin, M
    Pinel, MI
    Roriz, W
    Zamboni, MM
    Cunha, ET
    Cordeiro, PB
    Torquato, E
    Goncalves, MCC
    Campos, L
    ANNALS OF ONCOLOGY, 1998, 9 : 94 - 95
  • [10] Cetuximab in combination with concurrent chemoradiotherapy (CRT) in locally advanced non-small cell lung carcinoma (NSCLC): A feasibility study
    van den Heuvel, M. M.
    Belderbos, J.
    Dalesio, O.
    van der Pol, M.
    Uitterhoeve, L.
    van de Vaart, P.
    Verheij, M.
    van Zandwijk, N.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
12345